PL2004807T3 - Kompozycje do wytwarzania dojrzałych komórek dendrytycznych - Google Patents
Kompozycje do wytwarzania dojrzałych komórek dendrytycznychInfo
- Publication number
- PL2004807T3 PL2004807T3 PL07723717T PL07723717T PL2004807T3 PL 2004807 T3 PL2004807 T3 PL 2004807T3 PL 07723717 T PL07723717 T PL 07723717T PL 07723717 T PL07723717 T PL 07723717T PL 2004807 T3 PL2004807 T3 PL 2004807T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- production
- dendritic cells
- mature dendritic
- mature
- Prior art date
Links
- 210000004443 dendritic cell Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/46—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2301—Interleukin-1 (IL-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Mycology (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06006373A EP1840206A1 (en) | 2006-03-28 | 2006-03-28 | Compositions for the preparation of mature dendritic cells |
| US82582206P | 2006-09-15 | 2006-09-15 | |
| PCT/EP2007/002773 WO2007110240A1 (en) | 2006-03-28 | 2007-03-28 | Compositions for the preparation of mature dendritic cells |
| EP07723717.0A EP2004807B1 (en) | 2006-03-28 | 2007-03-28 | Compositions for the preparation of mature dendritic cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2004807T3 true PL2004807T3 (pl) | 2015-07-31 |
Family
ID=36441990
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07723717T PL2004807T3 (pl) | 2006-03-28 | 2007-03-28 | Kompozycje do wytwarzania dojrzałych komórek dendrytycznych |
| PL15157220T PL2918673T3 (pl) | 2006-03-28 | 2007-03-28 | Kompozycje do wytwarzania dojrzałych komórek dendrytycznych |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15157220T PL2918673T3 (pl) | 2006-03-28 | 2007-03-28 | Kompozycje do wytwarzania dojrzałych komórek dendrytycznych |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8679840B2 (pl) |
| EP (4) | EP1840206A1 (pl) |
| AU (1) | AU2007229640B2 (pl) |
| CA (1) | CA2647622C (pl) |
| CY (1) | CY1121448T1 (pl) |
| DK (2) | DK2918673T3 (pl) |
| ES (2) | ES2718525T3 (pl) |
| HU (1) | HUE042138T2 (pl) |
| PL (2) | PL2004807T3 (pl) |
| PT (2) | PT2918673T (pl) |
| SI (1) | SI2918673T1 (pl) |
| TR (1) | TR201904207T4 (pl) |
| WO (1) | WO2007110240A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1780220A1 (en) * | 2005-11-01 | 2007-05-02 | Charité - Universitätsmedizin Berlin | Use of CEACAM8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| WO2010049152A1 (en) * | 2008-10-29 | 2010-05-06 | Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) | Novel composition for the preparation of mature dendritic cells |
| US9034317B2 (en) | 2010-02-10 | 2015-05-19 | Immunicum Ab | Composition for inhibiting tumor cell proliferation |
| JP2013522309A (ja) * | 2010-03-15 | 2013-06-13 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 活性化した成熟樹状細胞を調製し保存するシステムおよび方法 |
| EP2617434A1 (en) * | 2012-01-20 | 2013-07-24 | Laboratorios Del. Dr. Esteve, S.A. | HIV-1 integrase deficient immunogens and methods for loading dendritic cells with said immunogens |
| WO2013127976A1 (en) * | 2012-03-02 | 2013-09-06 | Laboratorios Del Dr. Esteve, S.A. | Method for the preparation of dendritic cell vaccines |
| EP2913394B1 (en) * | 2012-12-18 | 2016-06-22 | Immunicum AB | Co-differentiation and activation of monocytes from allogeneic donors to provide pro-inflammatory dendritic cells |
| WO2015179469A2 (en) * | 2014-05-20 | 2015-11-26 | Kiromic, Llc | Methods and compositions for treating malignancies with dendritic cells |
| WO2017002045A1 (en) | 2015-06-30 | 2017-01-05 | Stemlab, Sa | A viable cell population, method for production and uses thereof |
| MX2018007842A (es) * | 2015-12-23 | 2018-11-09 | Medigene Immunotherapies Gmbh | Nueva generacion de tcr especificos de antigeno. |
| KR101946572B1 (ko) * | 2017-01-31 | 2019-02-11 | 주식회사 큐라티스 | 면역 관용성 플라즈마사이토이드 수지상 세포 및 그 제조방법 |
| GB201711379D0 (en) * | 2017-07-14 | 2017-08-30 | Univ Cape Town | Maturation of dendritic cells |
| WO2019048026A1 (en) * | 2017-09-05 | 2019-03-14 | Medigene Immunotherapies Gmbh | BIOLOGICAL ACTIVITY TEST OF DENDRITIC CELL |
| DK3460052T3 (da) * | 2017-09-20 | 2020-02-03 | Immunicum Ab | Forbedrede allogene dendrittiske celler til anvendelse i behandling af cancer |
| CN109182384A (zh) * | 2018-09-30 | 2019-01-11 | 北京鼎成肽源生物技术有限公司 | 一种rff1细胞的构建方法 |
| CN115068598A (zh) * | 2022-04-25 | 2022-09-20 | 福建医科大学孟超肝胆医院(福州市传染病医院) | Tlr激动剂以及包含新生抗原的免疫原性组合物在制备药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558951B1 (en) * | 1999-02-11 | 2003-05-06 | 3M Innovative Properties Company | Maturation of dendritic cells with immune response modifying compounds |
| ES2766299T3 (es) * | 2001-09-06 | 2020-06-12 | Northwest Biotherapeutics Inc | Composiciones y procedimientos para la activación linfocitaria de células dendríticas monocíticas y células T para generar una respuesta Th-1 |
| US20050003533A1 (en) * | 2003-05-08 | 2005-01-06 | Pawel Kalinski | Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use |
-
2006
- 2006-03-28 EP EP06006373A patent/EP1840206A1/en not_active Withdrawn
-
2007
- 2007-03-28 DK DK15157220.3T patent/DK2918673T3/en active
- 2007-03-28 PT PT15157220T patent/PT2918673T/pt unknown
- 2007-03-28 DK DK07723717.0T patent/DK2004807T3/en active
- 2007-03-28 TR TR2019/04207T patent/TR201904207T4/tr unknown
- 2007-03-28 EP EP18248089.7A patent/EP3517603A1/en not_active Withdrawn
- 2007-03-28 PL PL07723717T patent/PL2004807T3/pl unknown
- 2007-03-28 HU HUE15157220A patent/HUE042138T2/hu unknown
- 2007-03-28 PT PT77237170T patent/PT2004807E/pt unknown
- 2007-03-28 WO PCT/EP2007/002773 patent/WO2007110240A1/en not_active Ceased
- 2007-03-28 SI SI200732101T patent/SI2918673T1/sl unknown
- 2007-03-28 CA CA2647622A patent/CA2647622C/en active Active
- 2007-03-28 US US12/294,453 patent/US8679840B2/en active Active
- 2007-03-28 ES ES15157220T patent/ES2718525T3/es active Active
- 2007-03-28 PL PL15157220T patent/PL2918673T3/pl unknown
- 2007-03-28 ES ES07723717.0T patent/ES2535835T3/es active Active
- 2007-03-28 EP EP15157220.3A patent/EP2918673B1/en active Active
- 2007-03-28 AU AU2007229640A patent/AU2007229640B2/en not_active Ceased
- 2007-03-28 EP EP07723717.0A patent/EP2004807B1/en active Active
-
2014
- 2014-02-06 US US14/174,064 patent/US9512402B2/en not_active Expired - Fee Related
-
2016
- 2016-10-25 US US15/333,476 patent/US20170037372A1/en not_active Abandoned
-
2019
- 2019-03-20 CY CY20191100332T patent/CY1121448T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007110240A1 (en) | 2007-10-04 |
| US20140302096A1 (en) | 2014-10-09 |
| US20100284976A1 (en) | 2010-11-11 |
| CA2647622A1 (en) | 2007-10-04 |
| AU2007229640A1 (en) | 2007-10-04 |
| CA2647622C (en) | 2017-04-18 |
| SI2918673T1 (sl) | 2019-05-31 |
| PL2918673T3 (pl) | 2019-08-30 |
| EP2918673B1 (en) | 2019-01-16 |
| DK2004807T3 (en) | 2015-05-11 |
| PT2004807E (pt) | 2015-05-20 |
| ES2535835T3 (es) | 2015-05-18 |
| TR201904207T4 (tr) | 2019-05-21 |
| EP1840206A1 (en) | 2007-10-03 |
| US8679840B2 (en) | 2014-03-25 |
| EP2004807A1 (en) | 2008-12-24 |
| EP3517603A1 (en) | 2019-07-31 |
| US9512402B2 (en) | 2016-12-06 |
| CY1121448T1 (el) | 2020-05-29 |
| PT2918673T (pt) | 2019-04-23 |
| HUE042138T2 (hu) | 2019-06-28 |
| EP2004807B1 (en) | 2015-03-04 |
| ES2718525T3 (es) | 2019-07-02 |
| DK2918673T3 (en) | 2019-04-01 |
| US20170037372A1 (en) | 2017-02-09 |
| EP2918673A1 (en) | 2015-09-16 |
| AU2007229640B2 (en) | 2013-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2004807T3 (pl) | Kompozycje do wytwarzania dojrzałych komórek dendrytycznych | |
| EP2280916A4 (en) | HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN | |
| PT2209888T (pt) | Métodos aperfeiçoados de produção de células rpe e composições de células rpe | |
| BRPI0913806A2 (pt) | "composição" | |
| BRPI0810634A2 (pt) | Composições fungicidas | |
| DK2024406T3 (da) | Siliconacrylat-hybridpræparat | |
| DK2634232T3 (da) | Sammensætninger | |
| IL211138A0 (en) | Ih-benzimidazole-5-carboxamides as anti-inflammatory agents | |
| BRPI1011952A2 (pt) | "composições de combustível compreendendo derivados de isopreno" | |
| EP2024504A4 (en) | PREPARATION OF ISOPRENOIDES | |
| EP2225351A4 (en) | RENEWABLE COMPOSITIONS | |
| BRPI0909247A2 (pt) | Processos de produção de composições orais contendo redes de gel | |
| EP2037872A4 (en) | COMPOSITIONS COMPRISING BITULONIC ACID | |
| DK1993370T3 (da) | Forbedrede konfekturesammensætninger anvendende nanomaterialer | |
| BRPI0817946A2 (pt) | Composições de imatinibe estável | |
| DK2235145T3 (da) | Brændstofsammensætninger | |
| ZA200905134B (en) | Compositions of stable tiacumicins | |
| SI2470166T1 (sl) | Novi sestavki 1-(2-(2,4-dimetil-fenislulfanil)-fenil)piperazina | |
| NO20090054L (no) | Antitumoral dihydropyran-2-on sammensetninger | |
| EP2318306A4 (en) | NANOCOMPOSITES | |
| BR112013003385A2 (pt) | "composições e métodos para produzir células dentríticas" | |
| EP2099924A4 (en) | BIODIESEL PRODUCTION | |
| GB0713707D0 (en) | Stable compositions | |
| IL204950A0 (en) | Novel taxoid - based compositions | |
| ZA200806434B (en) | Calcium-enrichment compositions and methods for production thereof |